Property:Gender specifications
This is a property of type Text.
V
Gender per arm:
Enzyme arm: female = 3 (15.8%); male = 16 (84.2%)
Control arm: female = 5 (25%); male = 15 (75%) +
Vitale et al. (2020): ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy +
45 % female +
W
Walsh et al. (2010): Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma +
44% female, 56% male +
Watanabe et al. (2010): Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer +
Intervention arm: 13 male, 3 female
Control arm: 11 male, 4 female +
Williams et al. (1996): Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity +
? +
Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente +
Gender per arm:
Enzyme-arm: male = 23 (84.6%); female = 2(15.4%)
Control-arm: male = 22(92%); female = 4(8%) +
Wyatt et al. (2012): Health-Related Quality-of-Life Outcomes: A Reflexology Trial With Patients With Advanced-Stage Breast Cancer +
100 % female +
Wyatt et al. (2017): A Randomized Clinical Trial of Caregiver-Delivered Reflexology for Symptom Management During Breast Cancer Treatment +
Patients: 100 % female;
Caregivers: 40,8 % female +
Y
Yap et al. (2017): Predictors of hand-foot syndrome and pyridoxine for prevention of capecitabine-induced hand-foot syndrome: a randomized clinical trial +
Female n (%): 162 (77)
Male n (%): 48 (23) +
Z
Zalat et al. (2020): Evaluation of the cardioprotective effects of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy +
7.79% male +
Zick et al. (2008): Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting +
Female in %: Placebo arm: 76.9, 1.0-g ginger dose-arm: 73.6, 2.0-g ginger dose-arm: 75.4 +
Ö
Showing 1 related entity.